Neubase Therapeutics (64132K201) Held by Superinvestors
NEUBASE THERAPEUTICS INC (64132K201) is currently held by 1 superinvestors tracked by InsiderSet, with a combined reported market value of approximately $100,912 based on the latest available SEC Form 13F filings for the quarter ended December 31, 2023.
Greenlight Capital is currently the largest disclosed institutional shareholder of 64132K201 tracked by InsiderSet, reporting ownership valued at approximately $100,912 in its December 31, 2023 SEC Form 13F filing.
The top 10 institutional shareholders tracked on this page collectively account for approximately 100% of the total disclosed 64132K201 value among the investors covered in this analysis. Major shareholders include Greenlight Capital, and several other long-term asset managers with concentrated positions in NEUBASE THERAPEUTICS INC (64132K201).
This page ranks the largest institutional 64132K201 shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Greenlight Capital | David Einhorn | 0.00% | 136,350 | $100,912 | — | — | — |
Frequently asked questions about 64132K201
Who are the largest superinvestors holding 64132K201?
The largest superinvestors holding 64132K201 in the latest SEC Form 13F filings include Greenlight Capital. InsiderSet ranks these superinvestors by their latest reported 64132K201 position.
What does the 64132K201 superinvestors page include?
This page tracks 64132K201 positions reported by a curated group of notable institutional investors and fund managers through SEC Form 13F. NEUBASE THERAPEUTICS INC (64132K201) on this page reflects disclosed 13F holdings among those superinvestors, not every institutional shareholder of the stock.
How many superinvestors hold 64132K201?
InsiderSet currently tracks 1 superinvestors reporting 64132K201 holdings in the latest available 13F data. This is the curated set on this page, not the total number of institutions that own 64132K201.
How much 64132K201 stock do superinvestors hold?
Superinvestors tracked by InsiderSet disclosed approximately $100,912 in 64132K201 holdings for Q4 2023. This figure is reported 13F value as of the filing period, not necessarily today's market value, and it covers the curated superinvestors on this page rather than every institutional filer.
When were 64132K201 superinvestor holdings last updated?
The latest 64132K201 superinvestor holdings on InsiderSet are based on SEC Form 13F filings for the quarter ended December 31, 2023. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time holdings.
Are superinvestor 64132K201 holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by these superinvestors as of the end of the reporting quarter. A superinvestor may have changed its 64132K201 position after the reporting date.
Are superinvestors buying or selling 64132K201?
Buying and selling can be analyzed by comparing 64132K201 positions across consecutive 13F reporting periods. InsiderSet's 64132K201 Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View 64132K201 ownership changes.
How have superinvestor 64132K201 holdings changed over time?
InsiderSet tracks 64132K201 holdings among these superinvestors across multiple 13F reporting periods, so holder counts, reported value, and reported shares can be compared over time.